Andrew McPherson

Memorial Sloan Kettering Cancer Center

Full Professor(heuristic)

Cancer Genomics and Diagnostics · Cancer Research

h-index42

i10-index62

Publications165

Citations16,381

Grants

4 total · 3 active

NIH #5R37CA289752-03

Myeloma Defining Genomic Events to Differentiate Benign and Malignant Myeloma Precursor Conditions

Active

Amount: $753K
Period: 2025-02-03 → 2030-05-31
PIs: 2
Est. capacity / PI: ~4 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #7R37CA289752-02

Myeloma Defining Genomic Events to Differentiate Benign and Malignant Myeloma Precursor Conditions

Active

Amount: $674K
Period: 2025-02-03 → 2030-05-31
PIs: 2
Est. capacity / PI: ~4 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #1U01FD008299-01

Integrative proteogenomics for elucidation of tumor-specific cell surface proteomes in ultra-rare cancers

Active

Amount: $1.5M
Period: 2024-09-05 → 2027-08-31
PIs: 2
Est. capacity / PI: ~4 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

Lab Funding Health

Find elsewhere

Institution / lab homepage Search on ResearchGate

In-Field Influence

0.0010

PageRank within Cancer Research co-authorship network

Explore collaboration map

Admission Signals

New paper: Abstract 27: An MCP-enabled AI agent for automated multimodal genomics analysis in the Isabl Platform. (Cancer Research)2026-04-03
New preprint: End-to-end proteogenomics for discovery of cryptic and non-canonical cancer proteoforms using long-read transcriptomics and multi-dimensional proteomics2025-08-28
New NIH award: $753K — Myeloma Defining Genomic Events to Differentiate Benign and Malignant Myeloma Precursor Conditions2025-02-03
New NIH award: $674K — Myeloma Defining Genomic Events to Differentiate Benign and Malignant Myeloma Precursor Conditions2025-02-03
New NIH award: $1,496K — Integrative proteogenomics for elucidation of tumor-specific cell surface proteomes in ultra-rare cancers2024-09-05

Data Freshness

Publications as of 2026-07-01
Grants as of 2026-06-30

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

ORCID: 0000-0002-5654-5101

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 37

Abstract 27: An MCP-enabled AI agent for automated multimodal genomics analysis in the Isabl Platform.
Cancer Research · 2026-04-03
Abstract 3526: Dynamic evolution of oncogene amplification across 80,000 cancer cell genomes
Cancer Research · 2026-04-03
Abstract 4696: Oncogenic transcriptional rewiring in micronuclei
Cancer Research · 2026-04-03
End-to-end proteogenomics for discovery of cryptic and non-canonical cancer proteoforms using long-read transcriptomics and multi-dimensional proteomics
eLife · 2026-02-12
End-to-end proteogenomics for discovery of cryptic and non-canonical cancer proteoforms using long-read transcriptomics and multi-dimensional proteomics
eLife · 2026-02-12
Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer
Nature Communications · 2025-12-20 · 5 citations
Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology
Nature Communications · 2025-11-27 · 2 citations
Genomics define neoplastic transformation in multiple myeloma precursor conditions
Blood · 2025-11-03
Integrating single-cell whole genome and transcriptome sequencing to track the clonal evolution of TP53-mutated myeloid neoplasms
Blood · 2025-11-03
Protocol for a multicentre randomised controlled trial of the Pharmacy Homeless Outreach Engagement Non-medical and Independent Prescriber (PHOENIx) intervention for people facing severe and multiple disadvantages
BMJ Open · 2025-11-01
Genomics Define Malignant Transformation in Myeloma Precursor Conditions
Journal of Clinical Oncology · 2025-10-08 · 9 citations
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA
Nature · 2025-10-01 · 10 citations
A pilot randomised controlled trial of Tailored Intervention for people with moderate-to-severe Chronic Obstructive Pulmonary Disease and Co-morbidities delivered by Pharmacists and Consultant respiratory Physicians (TICC-PCP)
2025-09-27
End-to-end proteogenomics for discovery of cryptic and non-canonical cancer proteoforms using long-read transcriptomics and multi-dimensional proteomicsPreprint
bioRxiv (Cold Spring Harbor Laboratory) · 2025-08-28
Ongoing genome doubling shapes evolvability and immunity in ovarian cancer
Nature · 2025-07-16 · 36 citations
Abstract B054: Identification of spatial motifs linked to tumor genotype using graph attention networks
Clinical Cancer Research · 2025-07-10
FOXA2 promotes metastatic competence in small cell lung cancer
Nature Communications · 2025-05-26 · 10 citations
Complementary modes of resistance to <i>EGFR</i> TKI in lung adenocarcinoma through MAPK activation and cellular plasticityPreprint
bioRxiv (Cold Spring Harbor Laboratory) · 2025-05-10 · 2 citations
Disrupted priming within draining lymph nodes drives immune quiescence in gastric cancerPreprint
bioRxiv (Cold Spring Harbor Laboratory) · 2025-05-06
Abstract 4005: Integrative clinical and molecular characterization of an international community resource of organoid models of human cancer
Cancer Research · 2025-04-21

Open author page on OpenAlex →